Antisense Proliferating Cell Nuclear Antigen Oligonucleotides Inhibit Intimal Hyperplasia in a Rat Carotid Artery Injury Model.

Journal of Clinical Investigation - United States
doi 10.1172/jci117240
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Single Intraluminal Delivery of Antisense Cdc2 Kinase and Proliferating-Cell Nuclear Antigen Oligonucleotides Results in Chronic Inhibition of Neointimal Hyperplasia.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1993English

Novel Oral Formulation of Paclitaxel Inhibits Neointimal Hyperplasia in a Rat Carotid Artery Injury Model

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

UV Inducibility of Rat Proliferating Cell Nuclear Antigen Gene Promoter

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
1999English

Proliferating Cell Nuclear Antigen (PCNA) Expressed in Human Leptomeninges.

Journal of Histochemistry and Cytochemistry
AnatomyHistology
1996English

Proresolving Lipid Mediators Resolvin D1 and Protectin D1 Isomer Attenuate Neointimal Hyperplasia in the Rat Carotid Artery Balloon Injury Model

Journal of Surgical Research
Surgery
2019English

Proliferating Cell Nuclear Antigen Antibody Testing – Getting Them All

Pathology
Forensic MedicinePathology
2020English

P21CIP1 Controls Proliferating Cell Nuclear Antigen Level in Adult Cardiomyocytes

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2003English

Replication Protein a Dynamically Regulates Monoubiquitination of Proliferating Cell Nuclear Antigen

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2019English

Comparison of Proliferating Cell Nuclear Antigen to Tritiated Thymidine as a Marker of Proliferating Hepatocytes in Rats

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy